<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02519283</url>
  </required_header>
  <id_info>
    <org_study_id>150684</org_study_id>
    <nct_id>NCT02519283</nct_id>
  </id_info>
  <brief_title>Get With the Guidelines in ED Patients With Heart Failure</brief_title>
  <acronym>GUIDED-HF</acronym>
  <official_title>Get With the Guidelines in ED Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stony Brook University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wayne State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>MetroHealth Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Mississippi Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Approximately 20-30% of patients presenting with acute heart failure are discharged from the
      ED. Compared to patients discharged from the hospital, they more frequently return to the ED
      and hospital for further management. While inpatient discharges are often enrolled in
      transitions programs and have their care tailored to evidence-based recommendations, ED
      discharges do not. The investigators propose to evaluate current standard ED discharge to an
      ED-based intervention which will transition patients to outpatient follow-up on
      guideline-recommended therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure (HF) is common and growing healthcare concern. Heart failure affects nearly 6
      million Americans. It results in over one million annual hospital discharges as the primary
      discharge diagnosis and an additional two million hospitalizations where HF contributes to
      the discharge diagnosis. Despite a relative reduction in the hospitalization rate of HF, the
      actual number of HF hospitalizations remains over one million annually. This figure is
      expected to significantly worsen with the aging United States population and the growing HF
      prevalence. Over 80% of patients who are hospitalized are initially seen in the emergency
      department (ED). However, not all those seen in the ED for HF are admitted; a sizeable
      proportion are discharged home without hospitalization. As disposition decisions for those
      who present to the hospital rest largely with ED providers, the ED will play an even bigger
      role in the management of HF patients and in avoiding unnecessary hospitalizations.

      The ED is the gatekeeper for AHF evaluations. Nearly one million ED visits for acute heart
      failure (AHF) occur annually in the United States. Importantly, the ED is the safety net for
      AHF care and often sole provider of AHF care to vulnerable patients. To optimize care and
      reduce ED and hospital revisits, there has been significant emphasis on improving transitions
      at the time of hospital discharge for HF patients. Such efforts have been almost exclusively
      directed at hospitalized patients; individuals with AHF who are discharged from the ED miss
      the benefits of transitional care initiatives.

      Ensuring optimal transitions of care for discharged ED AHF patients is a critical unmet need.
      Data show AHF patients discharged from the ED receive suboptimal guideline directed medical
      therapy (GDMT), suggesting interventions to improve AHF transitions are needed in the ED
      setting. This is particularly true for patients that are in resource limited settings, many
      of whom have vulnerable characteristics. By default the ED is often the sole or primary
      provider of HF care to this group of patients who are discharged from the ED.

      The proposal, &quot;Get with the Guidelines in ED Patients with Heart Failure (GUIDED-HF)&quot;, is
      designed to answer two fundamental questions about vulnerable patients with AHF discharged
      from the ED:

        1. Does GWTG:HF implementation by a transition nurse coordinator directed team (TNC Team)
           reduce disparities in time to ED/clinic revisit or hospital admission or cardiovascular
           death over the 3-month period immediately following the index ED visit?

        2. Does GWTG:HF implementation by a TNC Team reduce disparities in patient satisfaction, HF
           knowledge and QOL over the 3-month period immediately following the index ED visit?

      Patients hospitalized for HF continue to have a high risk of adverse post-discharge outcomes.
      Although there has been a relative reduction in rehospitalization and mortality rates for AHF
      patients post-discharge after a significant recent effort by hospitals to avoid CMS financial
      penalties, the absolute risk remains very high. The one-month post discharge readmission risk
      is 20-25% and one-year post discharge mortality is 25-30%. These results are from
      institutions who have implemented significant in-hospital case management programs with a
      specific focus on transitions of care, including early post-discharge follow-up. ED patients
      discharged with AHF have more vulnerable characteristics, have a higher risk of readmission,
      and are not included in hospital programs targeted to help them. This proposal will study a
      significant unmet need, projected to get worse, and for which no evidence based data
      currently exist to guide management. Even a modest reduction in the risk for ED revisits or
      hospital admissions has the potential for significant clinical and patient centric benefits
      in patients with AHF discharged from the ED.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2015</start_date>
  <completion_date type="Actual">February 2020</completion_date>
  <primary_completion_date type="Actual">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Score Reflective of Clinical Status</measure>
    <time_frame>90 days from ED discharge</time_frame>
    <description>Participants ranked sequentially. Ranking stratified in 1 of 3 tiers based on:
Lowest tier: CV Death: Ranking based on time to death from original ED discharge date. Participant with the first death = lowest rank in the tier.
Middle tier: ED Re-visit, Hospital Re-admission or Clinic for AHF with IV. For patients alive, ranking based on time to ED Re-visit, Hospital Re-admission or Clinic for AHF with IV from original ED discharge date, whichever occurs first. Participant with first adverse event = lowest rank in the tier.
Highest tier: KCCQ Changes. For patients alive, ranking is based on changes in KCCQ from baseline. Participant with the largest decrease = lowest rank in the tier.
The use of 3 tiers reflects the greater adverse impact of death, followed by adverse impact of Hospital Re-admission, ED Re-visit, clinic for AHF with IV on clinical status, and then health status as measured by KCCQ. The Clinical Events (Composite) updated on 11/19/19 per PCORI study team discussion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HF Related Quality of Life: Kansas City Cardiomyopathy Questionnaire (KCCQ)</measure>
    <time_frame>Enrollment, 30 days and 90 days after ED discharge</time_frame>
    <description>The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 12-item self-administered questionnaire developed to independently measure the patient's perception of their health status. Scores range from 0 to 100, with higher scores indicating lower symptom burden and better QOL. Scores were divided into ranges of 0 to 25 (severe), 26 to 50 (moderate), 51 to 75 (fair), and 76 to 100 (little-to-no disability).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to Refills and Medications Scale (ARMS 7) score</measure>
    <time_frame>Enrollment, 30 days and 90 days after ED discharge</time_frame>
    <description>The ARMS consists of 7 questions administered verbally by healthcare professionals to assess self-reported adherence to medication for participants. Scores range from 7 to 28 with lower scores indicating better adherence and higher scores indicating worse adherence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety score</measure>
    <time_frame>Enrollment, 30 days and 90 days after ED discharge</time_frame>
    <description>The PROMIS Anxiety short form consists of 8 questions with five response options ranging in value from 1 to 5 to assess self-reported anxiety for participants. Scores range from 8 to 40. Higher scores indicate greater anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcomes Measurement Information System (PROMIS) Depression score</measure>
    <time_frame>Enrollment, 30 days and 90 days after ED discharge</time_frame>
    <description>The PROMIS Depression short form consists of 8 questions with five response options ranging in value from 1 to 5 to assess self-reported anxiety for participants. Scores range from 8 to 40. Higher scores indicate greater depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent at clinic office visits</measure>
    <time_frame>30 days and 90 days after ED discharge</time_frame>
    <description>Time spent at clinic office visits after ED discharge will be measured in minutes. Increased minutes indicate lower health status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Out-of-pocket costs for work missed</measure>
    <time_frame>30 days and 90 days after ED discharge</time_frame>
    <description>Out-of-pocket costs for time missed at work after ED discharge will be measured in dollars. Increased dollars indicate lower health status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dutch Heart Failure Knowledge score</measure>
    <time_frame>Enrollment, 30 days and 90 days after ED discharge</time_frame>
    <description>The Dutch Heart Failure Knowledge Scale is a 15-item, self-administered questionnaire that covers items concerning HF knowledge. Scores range from 0 to 15, where a score between 0 and 7 indicates a lack of awareness and a score between 8 and 15 indicates a complete knowledge of the disease.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">529</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In keeping with the strategy-based pragmatic nature of the trial, the discharge procedures will largely be kept as they are in common practice. Investigators will standardize usual care for ED discharge to include HF medication reconciliation as well as encourage 7-day follow-up.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GUIDED-HF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>GWTG:HF has been successfully implemented across multiple inpatient populations and health systems over the last decade and has been shown to improve HF disparities.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>GUIDED-HF</intervention_name>
    <description>Participants in this arm will receive a tailored discharge plan via a transition nurse coordinator directed team (TNC Team).
Disease education: Health literacy screen will identify barriers to understanding discharge and medication instructions.
Lifestyle interventions: Includes receiving smoking cessation information and instructions to track daily weights.
Guideline recommendations for medications and device referral: Includes determining the need for prescriptions for ACEIs, ARBs, beta blockers, aldosterone antagonists, anticoagulants and referral for pacemaker/defibrillator consideration.
Outpatient follow-up appointment: TNC Team will provide a scheduled appointment within 7 days and will conduct a home visit within 48 hours of ED discharge.</description>
    <arm_group_label>GUIDED-HF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>Those in the standard care arm will receive structured ED discharge assessment to include:
discharge instructions;
medication reconciliation
encourage follow-up.</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients deemed by emergency physician to have AHF, who they plan to discharge or hold
             for brief ED-based observation (less than 23 hours of AHF care)

          -  Age â‰¥21 years old

          -  Prior history of HF

        Exclusion Criteria:

          -  Unable to comply with protocol- due to psychiatric disease or distance from the
             hospital

          -  Systolic BP &lt;100 mmHg

          -  Evidence of ACS based on ischemia on ECG or Troponin elevation

          -  Outpatient inotrope infusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sean Collins, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Javed Butler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stony Brook University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stony Brook University</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MetroHealth</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Tennessee Valley Health System</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>July 31, 2015</study_first_submitted>
  <study_first_submitted_qc>August 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2015</study_first_posted>
  <last_update_submitted>April 17, 2020</last_update_submitted>
  <last_update_submitted_qc>April 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Sean Collins</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>AHF</keyword>
  <keyword>HF</keyword>
  <keyword>ED</keyword>
  <keyword>ER</keyword>
  <keyword>Emergency Department</keyword>
  <keyword>Emergency Room</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

